Table 2.

Modification or interruption of anticancer treatments because of COVID-19 diagnosis.

Anticancer treatment	Type of modification	Number (%)
Systemic therapy		N = 1092
	Modification of the regimen	53 (5%)
	Temporary interruption	321 (29%)
	Definitive interruption	110 (10%)
Radiotherapy		N = 1093
	Cancellation	1 (<1%)
	Modification of the radiation scheme	5 (<1%)
	Postponement	43 (4%)
	Definitive interruption	13 (1%)
Surgery		N = 1095
	Modification of the extent of surgery	1 (<1%)
	Cancellation	16 (2%)
	Postponement	24 (2%)
Interventional radiology		N = 1095
	Cancellation	2 (<1%)
	Postponement	3 (<1%)